(Nasdaq: PCVX), a clinical-stage vaccine innovation company, today announced that the first participants were dosed in the OPUS (OPA-based Pivotal U.S. Study) Phase 3 pivotal, noninferiority trial ...

Learn why child mortality is rising for the first time in our lives - and how smarter investments, innovation, and science ...

Merck , known as MSD outside the United States and Canada, announced today that the province of Saskatchewan has added CAPVAXIVE®, a 21-valent pneumococcal conjugate vaccine, to its publicly funded ...

Scientists engineered phages to act as scaffolds to carry silver nanoparticles. Together, the two bacteria-killing components ...

Pneumonia cases surge in winter as cold, pollution, and viruses weaken immunity. Dr. Agrawal urges early diagnosis, awareness ...

Kite, a Gilead Company , presented a new analysis today demonstrating that second-line Yescarta® (axicabtagene ciloleucel) therapy offers consistent benefits in patients with relapsed/refractory large ...

OS Therapies Inc. (NYSE American: OSTX) (“OS Therapies” or “the Company”), the world leader in listeria-based cancer ...

An investigation into cellular components in bacteria has unexpectedly uncovered a feature with relevance across many life ...

Colibactin is a powerful toxin produced by Escherichia coli and other bacteria living in the human gut. This highly unstable ...

Antibiotics are no longer able to treat infections as effectively as they once did because many pathogens have developed ...

The microbes inside our bodies not only help break down food but also impact our health. Yet their precise influence is not ...

A closeup look at colibactin’s structure reveals chemical motifs that guide its mutation-wreaking “warheads” to specific stretches of DNA.